Posts

Alopecia Treatment Market 2019

Alopecia Treatment Market 2019

Alopecia Treatment Market 2019 – Teva Pharmaceutical Industries, Merck, Reddy’s Laboratories, Cipla, Cellmid, Himalaya Drug, Taisho Pharmaceutical Holdings

The new report on the global Alopecia Treatment market provides key insights into the Alopecia Treatment market.

The market report is ideal for customers looking to gain actionable insights into the market which can assist them in furthering their business.

The global report provides a detailed analysis of all the parameters within the Alopecia Treatment market. The market report pegs the global Alopecia Treatment market at US$ XX million at the end of 2018 and shall keep a good CAGR of XX% throughout the forecast period. The global report covers the forecast period from 2018 – 2025. At the end of the forecast period, the Alopecia Treatment market is projected to reach the value of US$ XX million.

Get Free PDF Sample Brochure @ decisionmarketreports.com/request-sample?productID=1011763

Various factors affecting the forecasted trend in the Alopecia Treatment market are discussed in detail with analysis of the same. The global market report covers all the drivers, trends, and challenges in the market within the analysis and for the elucidation of the forecast statistics. Furthermore, the global market report is dissected and analysed across its various segments such as by product type, by application, by end users, and by region.

In terms of product type, the global Alopecia Treatment market is segmented into the following:

• Topical Drugs
• Oral Drugs
• Injectable
• Hair Transplant Services
• Other

Product X is currently leading in terms of value and volume owing to high demand from across all regions. Product Y is expected to gain traction since new technology and changing customers trends is expected to push the demand for it. Product Y is hence is expected to record the highest growth rate for the forecast period.

In terms of application, the global Alopecia Treatment market is segmented as follows:

• Hospitals
• Dermatology And Trichology Clinics
• Home Care Settings
• Other

Application X holds the highest share in the global Alopecia Treatment market. Application Y is expected to record the highest growth rate and can even surpass the market share of Application X by the end of the forecast period.

By end users, the global Alopecia Treatment market is segmented into:

• Teva Pharmaceutical Industries
• Merck
• Johnson&Johnson
• Reddy’s Laboratories
• Cipla
• Cellmid
• Himalaya Drug
• Taisho Pharmaceutical Holdings

End-user X is the highest share holder in terms of value and volume and End-user Y is expected to record a high growth rate for the forecast period based on the data of the changing market trends.

The global Alopecia Treatment market report provides a detailed analysis of the regional segmentation. The Alopecia Treatment market is segmented into the following regions:

• United States
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Region X is a more matured market and is the highest with US$ XX million in value at the end of 2018. Region Y is showcasing high growth rate as the overall income of the population is on the rise and people have a higher amount of disposable income available.

The global Alopecia Treatment market includes a detailed SWOT analysis and competitive landscape analysis as well that provides customers with key insights into what the top companies are working on. Every top player and their respective company profiles are covered in detail including the latest news and updates of acquisitions and mergers. For more details on the Alopecia Treatment market, visit our website here.

Table of Contents

Executive Summary

1 Alopecia Treatment Market Overview
2 Global Alopecia Treatment Market Competition by Manufacturers
3 Global Alopecia Treatment Production Market Share by Regions
4 Global Alopecia Treatment Consumption by Regions
5 Global Alopecia Treatment Production, Revenue, Price Trend by Type
6 Global Alopecia Treatment Market Analysis by Applications
7 Company Profiles and Key Figures in Alopecia Treatment Business
8 Alopecia Treatment Manufacturing Cost Analysis
9 Marketing Channel, Distributors and Customers
10 Market Dynamics
11 Global Alopecia Treatment Market Forecast
12 Research Findings and Conclusion
13 Methodology and Data Source

About Us

Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

 

Alopecia Treatment Market 2019

 

Source

 

Previous Posts

Alopecia Treatment Market 2019

Alopecia Treatment Market 2019

Alopecia Treatment Market 2019 – Teva Pharmaceutical Industries, Merck, Reddy’s Laboratories, Cipla, Cellmid, Himalaya Drug, Taisho Pharmaceutical Holdings

The new report on the global Alopecia Treatment market provides key insights into the Alopecia Treatment market.

The market report is ideal for customers looking to gain actionable insights into the market which can assist them in furthering their business.

The global report provides a detailed analysis of all the parameters within the Alopecia Treatment market. The market report pegs the global Alopecia Treatment market at US$ XX million at the end of 2018 and shall keep a good CAGR of XX% throughout the forecast period. The global report covers the forecast period from 2018 – 2025. At the end of the forecast period, the Alopecia Treatment market is projected to reach the value of US$ XX million.

Get Free PDF Sample Brochure @ decisionmarketreports.com/request-sample?productID=1011763

Various factors affecting the forecasted trend in the Alopecia Treatment market are discussed in detail with analysis of the same. The global market report covers all the drivers, trends, and challenges in the market within the analysis and for the elucidation of the forecast statistics. Furthermore, the global market report is dissected and analysed across its various segments such as by product type, by application, by end users, and by region.

In terms of product type, the global Alopecia Treatment market is segmented into the following:

• Topical Drugs
• Oral Drugs
• Injectable
• Hair Transplant Services
• Other

Product X is currently leading in terms of value and volume owing to high demand from across all regions. Product Y is expected to gain traction since new technology and changing customers trends is expected to push the demand for it. Product Y is hence is expected to record the highest growth rate for the forecast period.

In terms of application, the global Alopecia Treatment market is segmented as follows:

• Hospitals
• Dermatology And Trichology Clinics
• Home Care Settings
• Other

Application X holds the highest share in the global Alopecia Treatment market. Application Y is expected to record the highest growth rate and can even surpass the market share of Application X by the end of the forecast period.

By end users, the global Alopecia Treatment market is segmented into:

• Teva Pharmaceutical Industries
• Merck
• Johnson&Johnson
• Reddy’s Laboratories
• Cipla
• Cellmid
• Himalaya Drug
• Taisho Pharmaceutical Holdings

End-user X is the highest share holder in terms of value and volume and End-user Y is expected to record a high growth rate for the forecast period based on the data of the changing market trends.

The global Alopecia Treatment market report provides a detailed analysis of the regional segmentation. The Alopecia Treatment market is segmented into the following regions:

• United States
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Region X is a more matured market and is the highest with US$ XX million in value at the end of 2018. Region Y is showcasing high growth rate as the overall income of the population is on the rise and people have a higher amount of disposable income available.

The global Alopecia Treatment market includes a detailed SWOT analysis and competitive landscape analysis as well that provides customers with key insights into what the top companies are working on. Every top player and their respective company profiles are covered in detail including the latest news and updates of acquisitions and mergers. For more details on the Alopecia Treatment market, visit our website here.

Table of Contents

Executive Summary

1 Alopecia Treatment Market Overview
2 Global Alopecia Treatment Market Competition by Manufacturers
3 Global Alopecia Treatment Production Market Share by Regions
4 Global Alopecia Treatment Consumption by Regions
5 Global Alopecia Treatment Production, Revenue, Price Trend by Type
6 Global Alopecia Treatment Market Analysis by Applications
7 Company Profiles and Key Figures in Alopecia Treatment Business
8 Alopecia Treatment Manufacturing Cost Analysis
9 Marketing Channel, Distributors and Customers
10 Market Dynamics
11 Global Alopecia Treatment Market Forecast
12 Research Findings and Conclusion
13 Methodology and Data Source

About Us

Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

 

Alopecia Treatment Market 2019

 

Source

 

Previous Posts

Hairmore Novel Treatment for Traction Alopecia

Hairmore Novel Treatment for Traction Alopecia

Applied Biology to Enter into a License Agreement with Hairmore for its Novel Treatment for Traction Alopecia

APPLIED BIOLOGY’S NOVEL TAAR RECEPTOR AGONIST TO HELP MILLIONS OF CHINESE WOMEN SUFFERING FROM PONYTAIL INDUCED ALOPECIA

Applied Biology, Inc. (“Applied Biology”) announced today it has entered into a license agreement for the Chinese market for its novel TAAR receptor agonist for the treatment of ponytail induced alopecia.

A recent study conduct by Dr. Goren et al. demonstrated, that approximately 79% of women wearing a ponytail hair style four or more times per week for a period of at least ten years are at high risk for developing ponytail induced alopecia (also known as traction alopecia). No treatment exists for this condition.

While cessation of styling the hair in a ponytail avoids the development of this condition, a large majority of Chinese women continue to wear a ponytail hair style; thus, a prophylactic treatment that prevents the development of ponytail induced alopecia is of great clinical importance. Recently, Applied Biology scientists discovered a novel TAAR receptor agonist that when applied to scalp reduces the force exerted by the ponytail on hair follicles; thus, reduces the likelihood of development of ponytail alopecia.

According to Dr. Goren, Chief Medical Officer of Applied Biology: “China is the world’s second largest hair market. We are excited to team with the Hairmore Group, China’s premier hair surgery and treatment centers, to provide this groundbreaking therapy to women.”

ABOUT APPLIED BIOLOGY

Founded in 2003, Applied Biology is a biotechnology company located in Irvine, CA focused on the development of novel innovations for the treatment of hair disorders. Our focused team of scientists and physicians, have made breakthroughs in genetics, molecular biology mechanisms and clinical dermatology that are poised to improve millions of patients’ lives.

ABOUT HAIRMORE

Hairmore Group operating 17 surgical centers and over 100 clinics is the leader in hair surgery and hair treatment in China. With focus on quality of care through innovation, Hairmore is expanding its clinical excellence center throughout China and the world.

Applied Biology to Enter into a License Agreement with Hairmore for its Novel Treatment for Traction Alopecia

 

Source

 

Previous Posts

Treatment of alopecia universalis

Treatment of alopecia universalis

Treatment of alopecia universalis with topical Janus kinase inhibitors – a double-blind, placebo, and active-controlled pilot study

Background

Oral Janus kinase (JAK) inhibitors are currently being investigated in phase II and phase III clinical trials for several inflammatory skin diseases including alopecia areata (AA). Topical JAK inhibitors have been investigated in atopic dermatitis, psoriasis, and AA. While a number of case series using topical JAK inhibitors in AA have been published, to date there have been no randomized controlled clinical trials.

Methods

We conducted a phase I, 28-week prospective, placebo‐controlled, double‐blind study in patients with alopecia universalis investigating hair regrowth with two topical JAK inhibitors, 2% tofacitinib and 1% ruxolitinib. Topical clobetasol dipropionate 0.005% was the active comparator while vehicle was used as the placebo control. Sixteen patients were recruited for the study.

Results

Six patients demonstrated partial hair regrowth in areas treated with 2% tofacitinib ointment applied twice daily.

Five patients demonstrated partial hair regrowth in the areas treated with 1% ruxolitinib ointment.

Ten patients demonstrated partial hair regrowth in the areas treated with clobetasol dipropionate 0.05% ointment.

No regrowth was observed in the placebo-treated area. Interestingly, generalized hair regrowth was observed in two patients.

One patient had 100% regrowth over his entire scalp and eyebrows by week 24 but relapsed after 12 weeks.

A second patient also experienced generalized scalp regrowth and significant eyebrow growth and continued to maintain growth 14 weeks later.

Conclusion

Our findings suggest that topical JAK inhibitors could be developed as a potential new treatment for AA and alternative to clobetasol dipropionate 0.05% ointment.

Treatment of alopecia universalis with topical Janus kinase inhibitors – a double-blind, placebo, and active-controlled pilot study

Source

Previous Posts

Aclaris Therapeutics Provides Update on Clinical Trials

Aclaris Therapeutics Provides Update on Clinical Trials

Aclaris Therapeutics Provides Update on Oral and Topical JAK 1/3 Inhibitor Clinical Trials

Aclaris Therapeutics a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in dermatology, both aesthetic and medical, and immunology, today provided updated data from three clinical trials for ATI-502, an investigational topical Janus kinase (JAK) 1/3 inhibitor, an update on the expected release of topline data for one clinical trial for ATI-502, and an enrollment update for a clinical trial for ATI-501, an investigational oral JAK 1/3 inhibitor.

AA-202 Topical and AUATB-201 Topical are ongoing Phase 2 clinical trials of ATI-502 for the treatment of alopecia areata (AA) in the United States and Australia, respectively.

In AA-202 Topical, 11 patients with the more severe forms of AA, alopecia universalis (AU) and alopecia totalis (AT), were treated with ATI-502 in an initial double-blind pharmacokinetic and pharmacodynamic study for 28 days before entering a 12-month open-label extension.

In AUATB-201 Topical, an open-label clinical trial, 12 patients with eyebrow loss due to AA, including patients with AU or AT, had their eyebrows treated with ATI-502 for 6 months. VITI-201 Topical is an open-label pilot clinical trial of ATI-502 administered twice daily in 34 patients with non-segmental facial vitiligo.

As announced in November, Aclaris completed enrollment of AA-201 Topical, a randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the safety, efficacy and dose response of two concentrations of ATI-502 for the treatment of AA. This trial enrolled 129 patients with patchy AA, who were randomized to receive either ATI-502 or placebo.

The primary efficacy endpoint is the mean change from baseline in the Severity of Alopecia Tool (SALT) score at Week 24. Topline data from the AA-201 Topical trial are now expected in the second quarter of 2019.

In addition, Aclaris announced today that it has completed enrollment of AUAT-201 Oral, a randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the safety, efficacy and dose response of three concentrations of ATI-501 oral suspension for the treatment of AA. This trial enrolled 87 patients with AA, including AT and AU, who were randomized to receive either ATI-501 or placebo. The primary efficacy endpoint is the mean change from baseline in the SALT score at Week 24. Topline data from the AUAT-201 Oral trial are now expected in the third quarter of 2019.

“AA can be a psychologically devastating disease for which many patients do not have adequate options for treatment. Inhibition of the JAK1 and JAK3 pathways is an emerging therapeutic approach. We continue to advance our development programs for oral and topical formulations of JAK inhibitors with the goal of addressing the full spectrum of disease severity for patients living with AA,” said Dr. David Gordon, Chief Medical Officer of Aclaris.

Aclaris to Host Conference Call

Management will conduct a conference call at 5:00 PM ET today to discuss these updates.  The conference call will be webcast live over the Internet and can be accessed on the Events section of the Investors page of the Aclaris website at https://investor.aclaristx.com/events. A replay of the webcast will be archived on the Aclaris website for 30 days following the call. An accompanying slide deck with photos will be included as an exhibit to a Current Report on Form 8-K that Aclaris will furnish to the SEC today.

About Alopecia Areata

Alopecia areata (AA) is an autoimmune disease characterized by partial or complete loss of hair on the scalp, face or body. The scalp is the most commonly affected area. Onset of AA may occur in childhood and most patients experience onset by age 40. The course of disease is unpredictable and may involve spontaneous hair regrowth and sudden hair loss. Over half of patients with AA experience poor health-related quality of life. The disease can be associated with serious psychological consequences, including anxiety and depression. AA affects up to 1.8% of people in the United States and 2.0% of people globally at some point during their lives.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to address significant unmet needs in dermatology, both aesthetic and medical, and immunology. Aclaris’ focus on market segments with no FDA-approved medications or where treatment gaps exist has resulted in the first FDA-approved treatment for raised seborrheic keratoses and several clinical programs to develop medications for the potential treatment of common warts, alopecia areata, and vitiligo. For additional information, please visit www.aclaristx.com and follow Aclaris on LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

Aclaris Therapeutics Provides Update on Oral and Topical JAK 1/3 Inhibitor Clinical Trials

Source

 

Previous Posts

[print-me target=”body”]

Alopecia Market Research 2018

Alopecia Market Research 2018

Alopecia Market Research 2018 with top Countries data: Region Wise Analysis of Top Players in Market by its Types and Application and Forecast to 2023

Alopecia Market provides deep understanding, clarifies varieties of the market to help you decide not only the succeeding strategy but also to achieve the desired market position. This market research is a combined result of inputs from industry experts with awareness, the experience of Alopecia market and qualitative and quantitative synthesis of the market.

Description: Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues.

Top key players of the industry are covered in Alopecia Market Research Report:

  • Lifes2good, Kirkland Signature, Johnson & Johnson, Dr. Reddy’s Laboratories., Cipla., Alpecin., Vitabiotics., Sun Pharma., Phyto Ales Group…

The worldwide market for Alopecia Market is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2018.

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into:

  • Oral treatment, Topical treatment, Other treatment…

Split by application, this report focuses on consumption, market share and growth rate of Alopecia market in each application and can be divided into:

  • Male, Female

Global Alopecia Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

  • North America (the USA, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America (Brazil, Argentina, Columbia, etc.)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Target Audience of Alopecia Market:

  • Manufacturer / Potential Investors
  • Traders, Distributors, Wholesalers, Retailers, Importers, and Exporters.
  • Association and government bodies.

Alopecia Market Influencing Factors:

  • Market Environment: Government Policies, Technological Changes, Market Risks.
  • Market Drivers: Growing Demand, Reduction in Cost, Market Opportunities and Challenges.

Key questions answered in the Alopecia Market report:

  • What will the Alopecia market size and the growth rate be in 2023?
  • What are the key market trends impacting the growth of the Alopecia market?
  • Who are the global key manufacturers of Alopecia industry: Company Introduction, Product Specification, and Major Types Analysis, Production Market Performance, Sales Market Performance, Contact Information.
  • What are the types and applications of Alopecia? What is the market share of each type and application: production, revenue, price, Market Size (Sales) Market Share by Type.
  • What are the upstream raw materials and manufacturing equipment of Alopecia? Up Stream Industries Analysis, Raw Material and Suppliers, Equipment and Suppliers, Manufacturing Analysis, Manufacturing Process, Manufacturing Cost Structure, Manufacturing Plants Distribution Analysis, Industry Chain Structure Analysis
  • What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Alopecia?
  • What are the Alopecia market opportunities and threats faced by the vendors in the global Alopecia Industry?

Alopecia Market Research 2018 with top Countries data

Source

Global Alopecia Market Professional Survey

Global Alopecia Market Professional Survey

Global Alopecia Market Professional Survey Report 2018

Research Methodology

Global Alopecia market is anticipated to grow at a CAGR of XX% by 2023, according to a new report published by Marketintelligencedata Inc. The report segments the market and forecasts its size, by volume and value, on the basis of application, by-products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The Global Market for Alopecia to 2023 offers detailed coverage of guanidine Alopecia industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end use demand details, price trends, and company shares of the leading Alopecia producers to provide exhaustive coverage of the guanidine carbonate.

This research report includes the following contents:

  • Alopecia Product details, including pictures and technical specifications
  • Alopecia manufacturers, distributors, and channels
  • Major players present in the Alopecia
  • Information on competitor market shares, revenue, unit sales, etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

Key vendors:

  • Lifes2good
  • Kirkland Signature
  • Johnson & Johnson
  • Dr. Reddy’s Laboratories.
  • Cipla.
  • Alpecin.
  • Vitabiotics.
  • Sun Pharma.
  • Phyto Ales Group

Key regions:

North America, Europe, China, Japan, India, Southeast Asia, Other regions (Central & South America, Middle East & Africa)

Additionally, the market is segmented by the following sectors

  • Oral treatment
  • Topical treatment
  • Other treatment

Not only this, figures covering the end-user applications are also provided according to the following classification

  • Male
  • Female

In summary, the report serves to study and analyze the Alopecia size (value & volume) by the company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alopecia, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares split, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyze and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

Global Alopecia Market Professional Survey Report 2018

Source

Alopecia Treatment Market Outlook

Alopecia Treatment Market Outlook

Alopecia Treatment Market Outlook; Development Trends, Market Demands & Forecast by 2023 Industry Key players

Alopecia Treatment Market By Disease Type (Androgenic Alopecia, Cicatricial Alopecia, Alopecia Areata, Traction Alopecia and Alopecia Totalis) By Treatment Type (Topical Drugs, Injectable, Low Level Laser Therapy, Oral Drugs and Hair Transplant Services) By End-User (Homecare Settings, Dermatology Clinics and Others)- Global Industry Analysis & Forecast to 2023

Alopecia Treatment Market: Industry Outlook and Trend Analysis

The Alopecia Treatment Market has encountered significant development in recent years and is anticipated to grow tremendously over the forecast period. Alopecia also recognized as hair-loss or baldness is a medicinal condition that alludes to the loss of hairs from the head or any part of the body. The condition can happen in both male and female and at any age.

There are five main kinds of alopecia to be specific; androgenic alopecia, cicatricial alopecia, androgenic alopecia, alopecia totalis, and traction alopecia. Development of the alopecia treatment market is fundamentally determined by expanding interest in hair loss treatment drugs with improved viability and insignificant reactions. For instance, as of late cytokine therapy too regenerative cell treatment is picking up demand for treatment of different sorts of alopecia.

Alopecia Treatment Market Competitive Insights:

The leading players in the market are Ranbaxy Laboratories, Dr. Reddy’s Laboratories, Nanogen, Merck & Co, Vitabiotics, Viviscal, Kirkland Signature, Cipla, Phyto – Alès Groupe and Johnson and Johnson. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Alopecia Treatment Market: Treatment Type Outlook

Topical medications incorporate lotions, gels, creams, foam, and shampoos, while the injectable treatment composes section incorporates steroids, platelet-rich plasma therapy, and injectable fillers. Propecia, an oral drug is at present the main FDA affirmed medication in the treatment of alopecia. Restricted clinical efficacy exhibited by such medicines would hamper market and income development of established products over the figure time frame.

Alopecia Treatment Market: End User Outlook

Dermatology and trichology clinics section is the most elevated income supporter of the alopecia treatment market trailed by home care settings and end-user portions. Over the counter distribution and rising level of e-Commerce, implementation is anticipated to prompt an expanded selection of topical hair loss treatments in home care settings.

Alopecia Treatment Market: Regional Outlook and Trend Analysis

North America, trailed by Europe, is foreseen to overwhelm the alopecia treatment market all through the conjecture time frame. The Asia Pacific is anticipated to witness the speediest development attributable to the upheaval of a middle-aged populace in the area. Likewise, the district is observing sound development as far as GDP, which is anticipated to move development at solid digits. The Middle East and Africa and Latin America are foreseen to encounter sluggish development amid the conjecture time frame.

Major Table of Contents:

Chapter1. Introduction

Chapter2. Executive Summary

Chapter3. Market Overview

Chapter4.Market Analysis by Regions

Chapter5. Alopecia Treatment Market, By Disease Type

Chapter6. Alopecia Treatment Market, By Treatment Type

Chapter7. Alopecia Treatment Market, By End User

Chapter8. Alopecia Treatment Market, By Region

Alopecia Treatment Market Research Methodology:

We use both primary as well as secondary research for our market surveys, estimates and for developing the forecast. Our research process commences by analyzing the problem which enables us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to the changing nature of products and markets while retaining the core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers a one-stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Alopecia Treatment Market Outlook

Source

Global Alopecia Drugs Market Insights Forecast to 2025

Global Alopecia Drugs Market Insights Forecast to 2025

Global Alopecia Drugs Market Insights Forecast to 2025

This report studies the global market size of Alopecia Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa focuses on the consumption of Alopecia Drugs in these regions.

This research report categorizes the global Alopecia Drugs market by players/brands, region, type, and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

Alopecia drugs are being used for unapproved clinical indication or extension to a milder form of approved indication or extension to related conditions. For instance, alopecia market heavily uses spironolactone and cyclosporine, which are primarily approved for other indications.

The global topical drugs market segment accounted for the maximum market share during 2017 and will continue to dominate the market until the end of 2025. Topical drugs are widely used in comparison to oral formulations. The increasing availability and popularity of new drugs, such as the AVODART drug, will fuel the growth prospects for the market during the forecast period.

In 2017, the global Alopecia Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Alopecia Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Alopecia Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Alopecia Drugs include

GlaxoSmithKline
Johnson & Johnson
Merck
Aclaris Therapeutics
Polichem
Promius Pharma
Ranbaxy Laboratories
Reckitt Benckiser
Regience
Samumed
RepliCel
Skinvisible Pharmaceuticals
Teva Pharmaceutical
Market Size Split by Type
Oral Alopecia Drugs
Topical Alopecia Drugs
Injectable Alopecia Drugs
Market Size Split by Application
Hospitals
Specialty Clinics
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:

To study and analyze the global Alopecia Drugs market size (value & volume) by the company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Alopecia Drugs market by identifying its various sub-segments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Alopecia Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in the next few years.

To analyze the Alopecia Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Alopecia Drugs submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Alopecia Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alopecia Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Alopecia Drugs Market Insights Forecast to 2025

Source

Global and Chinese Alopecia Industry 2018 Market Research

Global and Chinese Alopecia Industry 2018 Market Research

Global and Chinese Alopecia Industry 2018 Market Research report

The ‘Global and Chinese Alopecia Industry, 2013-2023 Market Research Report’ is a professional and in-depth study on the current state of the global Alopecia industry with a focus on the Chinese market.

The report provides key statistics on the market status of the Alopecia manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for each company.

Through the statistical analysis, the report depicts the global and Chinese total market of Alopecia industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.

The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2018-2023 market development trends of Alopecia industry.

Analysis of upstream raw materials, downstream demand and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Alopecia Industry before evaluating its feasibility.

Overall, the report provides an in-depth insight of 2013-2023 global and Chinese Alopecia industry covering all important parameters.

TOC of Global and Chinese Alopecia Industry, 2018 Market Research Report

Chapter One Introduction of Alopecia Industry

Chapter Two Manufacturing Technology of Alopecia

Chapter Three Analysis of Global Key Manufacturers

Chapter Four 2013-2018 Global and Chinese Market of Alopecia

Chapter Five Market Status of Alopecia Industry

Chapter Six 2018-2023 Market Forecast of Global and Chinese Alopecia Industry

Chapter Seven Analysis of Alopecia Industry Chain

Chapter Eight Global and Chinese Economic Impact on Alopecia Industry

Chapter Nine Market Dynamics of Alopecia Industry

Chapter Ten Proposals for New Project

Chapter Eleven Research Conclusions of Global and Chinese Alopecia Industry

Global and Chinese Alopecia Industry 2018 Market Research report

Source

Global Alopecia Market Insights, Forecast to 2025

Global Alopecia Market Insights, Forecast to 2025

Global Alopecia Market Insights, Forecast to 2025

Global Alopecia (Hair Loss Treatment) market is anticipated to grow at a CAGR of XX% by 2023, according to a new report published by ResearchVector Inc.

The report segments the market and forecasts its size, by volume and value, on the basis of application, by-products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The Global Market for Alopecia (Hair Loss Treatment) to 2023 offers detailed coverage of guanidine Alopecia (Hair Loss Treatment) industry and presents main market trends. The market research gives historical and forecast market size, demand, and production forecasts, end use demand details, price trends, and company shares of the leading Alopecia (Hair Loss Treatment) producers to provide exhaustive coverage of the guanidine carbonate.

This research report includes the following contents:

  • Alopecia (Hair Loss Treatment) Product details, including pictures and technical specifications
  • Alopecia (Hair Loss Treatment) manufacturers, distributors and channels
  • Major players present in the Alopecia (Hair Loss Treatment)
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

Key vendors:

  • Shiseido
  • Rohto
  • Unilever
  • Taisho
  • Angfa
  • LOreal
  • Kaminomoto
  • Merck
  • Yanagiya Honten
  • Amorepacific
  • Procter & Gamble
  • Himalaya
  • Gerolymatos International
  • Merz Pharma
  • Leader Teck
  • Vasu Healthcare
  • VLCC
  • Ales Group
  • Shanxi Ante
  • Wansheng Pharmaceutical
  • Advanced Skin and Hair
  • Humanwell Healthcare
  • Topfond
  • Lifes2good
  • Bawang
  • YNK Pharmaceutical
  • Apollo
  • Jingxiutang
  • Rogaine
  • Marico

Key regions:

United States, Canada, Mexico, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Malaysia, Philippines, Thailand, Vietnam, Germany, France, UK, Italy, Spain, Russia, Brazil, Rest of Central & South America, GCC Countries, Turkey, Egypt, South Africa

Additionally, the market is segmented by the following sectors

  • Shampoos and Conditioners
  • Medicine Product

Not only this, but figures covering the end-user applications are also provided according to the following classification

  • Men
  • Women

In summary, the report serves to study and analyse the Alopecia (Hair Loss Treatment) size (value & volume) by the company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT).

Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alopecia (Hair Loss Treatment), to estimate the size of various other dependent submarkets in the overall market.

Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares split, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

Number of Pages 148

Published Date12 September 2018

Single User Price $3900.0

Enterprise User Price$7800.0

Global Alopecia Market Insights, Forecast to 2025

Source